221 related articles for article (PubMed ID: 28541500)
1. Prophylactic Efficacy of Hyperimmune Bovine Colostral Antiadhesin Antibodies Against Enterotoxigenic Escherichia coli Diarrhea: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial.
Savarino SJ; McKenzie R; Tribble DR; Porter CK; O'Dowd A; Cantrell JA; Sincock SA; Poole ST; DeNearing B; Woods CM; Kim H; Grahek SL; Brinkley C; Crabb JH; Bourgeois AL
J Infect Dis; 2017 Jul; 216(1):7-13. PubMed ID: 28541500
[TBL] [Abstract][Full Text] [Related]
2. Hyperimmune Bovine Colostral Anti-CS17 Antibodies Protect Against Enterotoxigenic Escherichia coli Diarrhea in a Randomized, Doubled-Blind, Placebo-Controlled Human Infection Model.
Savarino SJ; McKenzie R; Tribble DR; Porter CK; O'Dowd A; Sincock SA; Poole ST; DeNearing B; Woods CM; Kim H; Grahek SL; Brinkley C; Crabb JH; Bourgeois AL
J Infect Dis; 2019 Jul; 220(3):505-513. PubMed ID: 30897198
[TBL] [Abstract][Full Text] [Related]
3. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
[TBL] [Abstract][Full Text] [Related]
4. Oral delivery of Hyperimmune bovine serum antibodies against CS6-expressing enterotoxigenic
Talaat KR; Porter CK; Bourgeois AL; Lee TK; Duplessis CA; Maciel M; Gutierrez RL; DeNearing B; Adjoodani B; Adkinson R; Testa KJ; Feijoo B; Alcala AN; Brubaker J; Beselman A; Chakraborty S; Sack D; Halpern J; Trop S; Wu H; Jiao J; Sullivan E; Riddle MS; Joseph SS; Poole ST; Prouty MG
Gut Microbes; 2020 Nov; 12(1):1732852. PubMed ID: 32167011
[TBL] [Abstract][Full Text] [Related]
5. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
[TBL] [Abstract][Full Text] [Related]
6. Antibodies induced by enterotoxigenic Escherichia coli (ETEC) adhesin major structural subunit and minor tip adhesin subunit equivalently inhibit bacteria adherence in vitro.
Seo H; Nandre RM; Nietfeld J; Chen Z; Duan Q; Zhang W
PLoS One; 2019; 14(5):e0216076. PubMed ID: 31042746
[TBL] [Abstract][Full Text] [Related]
7. Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers.
Otto W; Najnigier B; Stelmasiak T; Robins-Browne RM
Scand J Gastroenterol; 2011 Jul; 46(7-8):862-8. PubMed ID: 21526980
[TBL] [Abstract][Full Text] [Related]
8. Mapping the Neutralizing Epitopes of Enterotoxigenic Escherichia coli K88 (F4) Fimbrial Adhesin and Major Subunit FaeG.
Lu T; Moxley RA; Zhang W
Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926730
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates.
Sincock SA; Hall ER; Woods CM; O'Dowd A; Poole ST; McVeigh AL; Nunez G; Espinoza N; Miller M; Savarino SJ
Vaccine; 2016 Jan; 34(2):284-291. PubMed ID: 26597148
[TBL] [Abstract][Full Text] [Related]
10. Antibodies derived from an enterotoxigenic Escherichia coli (ETEC) adhesin tip MEFA (multiepitope fusion antigen) against adherence of nine ETEC adhesins: CFA/I, CS1, CS2, CS3, CS4, CS5, CS6, CS21 and EtpA.
Nandre RM; Ruan X; Duan Q; Sack DA; Zhang W
Vaccine; 2016 Jun; 34(31):3620-5. PubMed ID: 27228947
[TBL] [Abstract][Full Text] [Related]
11. Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea.
Zhang W; Sack DA
Clin Vaccine Immunol; 2015 Sep; 22(9):983-91. PubMed ID: 26135975
[TBL] [Abstract][Full Text] [Related]
12. Bioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic Escherichia coli Hyperimmune Bovine Colostrum Products.
Sears KT; Tennant SM; Reymann MK; Simon R; Konstantopoulos N; Blackwelder WC; Barry EM; Pasetti MF
Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637804
[TBL] [Abstract][Full Text] [Related]
13. Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal.
Tacket CO; Losonsky G; Livio S; Edelman R; Crabb J; Freedman D
J Infect Dis; 1999 Dec; 180(6):2056-9. PubMed ID: 10558970
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
Fairbrother JM; Nadeau É; Bélanger L; Tremblay CL; Tremblay D; Brunelle M; Wolf R; Hellmann K; Hidalgo Á
Vaccine; 2017 Jan; 35(2):353-360. PubMed ID: 27916413
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA
Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889
[TBL] [Abstract][Full Text] [Related]
16. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
Evans DG; Graham DY; Evans DJ
Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
[TBL] [Abstract][Full Text] [Related]
17. Multiepitope fusion antigen induces broadly protective antibodies that prevent adherence of Escherichia coli strains expressing colonization factor antigen I (CFA/I), CFA/II, and CFA/IV.
Ruan X; Knudsen DE; Wollenberg KM; Sack DA; Zhang W
Clin Vaccine Immunol; 2014 Feb; 21(2):243-9. PubMed ID: 24351757
[TBL] [Abstract][Full Text] [Related]
18. Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli.
Freedman DJ; Tacket CO; Delehanty A; Maneval DR; Nataro J; Crabb JH
J Infect Dis; 1998 Mar; 177(3):662-7. PubMed ID: 9498445
[TBL] [Abstract][Full Text] [Related]
19. Cross-Reactivity, Epitope Mapping, and Potency of Monoclonal Antibodies to Class 5 Fimbrial Tip Adhesins of Enterotoxigenic Escherichia coli.
Liu Y; Shahabudin S; Farid S; Lee LH; McVeigh AL; Maciel M; Poole ST; Broadman M; Prouty MG; Savarino SJ
Infect Immun; 2020 Oct; 88(11):. PubMed ID: 32839190
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a single oral dose of a live bivalent E. coli vaccine against post-weaning diarrhea due to F4 and F18-positive enterotoxigenic E. coli.
Nadeau É; Fairbrother JM; Zentek J; Bélanger L; Tremblay D; Tremblay CL; Röhe I; Vahjen W; Brunelle M; Hellmann K; Cvejić D; Brunner B; Schneider C; Bauer K; Wolf R; Hidalgo Á
Vet J; 2017 Aug; 226():32-39. PubMed ID: 28911838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
